Yahoo Malaysia Web Search

Search results

  1. Children ages 6 months up to age 4 years are up to date after three doses of the 2024-2025 Pfizer-BioNTech COVID-19 vaccine. If a child has had one dose of a previous Pfizer-BioNTech COVID vaccine, two doses of the 2024-2025 Pfizer-BioNTech COVID-19 vaccine will bring the child up to date.

  2. children who are CONTRAINDICATED to receive Comirnaty® (Pfizer- BioNTech) vaccine (e.g. due to known allergy to Comirnaty ® excipients or severe adverse reaction to previous dose of Comirnaty ® vaccine).

  3. Feb 2, 2022 · Children under 12 will be offered Pfizer vaccines but it is a different formulation from the one that’s given to adults and children aged 12 and above. For children aged 5 to 11 years old, they will be given a less potent formulation and the vial gets an orange cap, instead of purple for adults.

  4. Mar 6, 2022 · Parents can now choose Sinovac instead of Pfizer for their children aged 5-11 years old. Kids will get their second Sinovac dose four weeks after getting the first jab.

  5. Sep 16, 2024 · Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Comirnaty is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based on clinical trials and continued monitoring.

  6. Jun 10, 2022 · A large phase 3 trial in Brazil showed that two doses, administered at an interval of 14 days, had an efficacy of 51% against symptomatic SARS-CoV-2 infection, 100% against severe COVID-19, and 100% against hospitalization starting 14 days after receiving the second dose.

  7. Mar 4, 2022 · Malaysia has given the green light for Sinovac vaccines to vaccinate children under 12. According to Khairy, Pfizer is still the preferred vaccine for children aged 5-11 who has no history of allergies.